New Bradford centre starts next covid-19 vaccine trial stage

The National Patient Recruitment Centres (NPRCs), which are now operational and recruiting, are part funded through an investment from the Government’s Life Sciences Industrial Strategy and Sector Deal 2 – a series of measures aiming to strengthen the UK environment for clinical research.

The centre is managed by and funded through the National Institute for Health Research and run locally by Bradford Teaching Hospitals NHS Foundation Trust.

The centre specialises in recruiting non-hospitalised patients with common chronic health conditions – such as asthma, irritable bowel syndrome (IBS), type 2 diabetes, and cardiovascular disease – conditions commonly managed by primary and community health services.

The centres will also play a pivotal role in delivering and helping people take part in vital Covid-19 vaccine studies. The Novavax Phase 3 Covid-19 vaccine trial is already underway at Patient Recruitment Centre: Bradford.

They are spread across England with a wide geographical catchment area to increase opportunities and make it easier for people in regions across the country to take part in studies and potentially benefit from innovation through clinical research.

Jess, a transformation manager from Yorkshire and Humber, took part in the Novavax study at the Patient Recruitment Centre in Bradford.

After attending the PRC to receive her first dose as part of the vaccine study, she said: “Taking part couldn’t have been a better process. I was sent lots of information and had the opportunity to read everything I was signing up to before I actually did it. A consultant took my consent and after some tests I was given the dose and put under observation. I have to go back on day 21 for my second dose and if at any point I think I have symptoms of Covid I have a dedicated number to call. I think I’m well supported and the staff made a real difference.

“I’m pleased to be able to play a small part in the study –  [the pandemic] isn’t going away until we have people taking part actively in these studies and without the collective efforts of all the people working on vaccines, we aren’t going to be able to beat the virus.”